Holen Sie sich die Stockscreener-App
22.78
3.52%
-0.83
Handel nachbörslich:
22.78
Schlusskurs vom Vortag:
$23.61
Offen:
$23.52
24-Stunden-Volumen:
1.43M
Relative Volume:
1.19
Marktkapitalisierung:
$1.51B
Einnahmen:
$5.79M
Nettoeinkommen (Verlust:
$-199.61M
KGV:
-7.5681
EPS:
-3.01
Netto-Cashflow:
$-188.48M
1W Leistung:
+1.79%
1M Leistung:
+4.50%
6M Leistung:
+13.90%
1J Leistung:
-48.85%
1-Tages-Spanne:
$22.34
$23.57
1-Wochen-Bereich:
$21.71
$23.69
52-Wochen-Spanne:
$14.40
$47.00
Celldex Therapeutics Inc Stock (CLDX) Company Profile
Firmenname
Celldex Therapeutics Inc
Sektor
Branche
Telefon
908-200-7500
Adresse
53 FRONTAGE ROAD, HAMPTON
Vergleichen Sie CLDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLDX
Celldex Therapeutics Inc
|
22.78 | 1.46B | 5.79M | -199.61M | -188.48M | -3.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Celldex Therapeutics Inc Stock (CLDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-03-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-02-13 | Eingeleitet | UBS | Buy |
| 2024-10-07 | Eingeleitet | Citigroup | Buy |
| 2024-09-30 | Eingeleitet | Goldman | Neutral |
| 2024-09-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-06-18 | Eingeleitet | Stifel | Buy |
| 2024-06-11 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-20 | Eingeleitet | TD Cowen | Outperform |
| 2023-11-10 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-08-22 | Eingeleitet | Wells Fargo | Underweight |
| 2021-09-17 | Eingeleitet | Jefferies | Buy |
| 2021-09-10 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-22 | Eingeleitet | Guggenheim | Buy |
| 2020-02-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-08-01 | Fortgesetzt | H.C. Wainwright | Buy |
| 2016-11-07 | Eingeleitet | Aegis Capital | Buy |
| 2016-03-08 | Herabstufung | Jefferies | Buy → Hold |
| 2016-03-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2016-03-07 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2016-03-07 | Herabstufung | Wedbush | Outperform → Neutral |
| 2016-03-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-08-11 | Bestätigt | Brean Capital | Buy |
| 2015-08-11 | Bestätigt | Oppenheimer | Outperform |
| 2015-08-11 | Bestätigt | ROTH Capital | Buy |
| 2015-06-02 | Bestätigt | WBB Securities | Strong Buy |
| 2014-11-17 | Bestätigt | ROTH Capital | Buy |
| 2014-03-04 | Bestätigt | Oppenheimer | Outperform |
| 2013-07-08 | Bestätigt | Cantor Fitzgerald | Buy |
| 2013-03-08 | Bestätigt | Cantor Fitzgerald | Buy |
| 2013-02-26 | Bestätigt | Oppenheimer | Outperform |
| 2013-01-10 | Bestätigt | Cantor Fitzgerald | Buy |
| 2012-10-02 | Bestätigt | Oppenheimer | Outperform |
| 2012-09-14 | Bestätigt | Cantor Fitzgerald | Buy |
Alle ansehen
Celldex Therapeutics Inc Aktie (CLDX) Neueste Nachrichten
What indicators show strength in Celldex Therapeutics Inc.Market Activity Report & Daily Profit Maximizing Trade Tips - Newser
Technical analysis overview for Celldex Therapeutics Inc. stockWeekly Market Summary & Reliable Breakout Stock Forecasts - Newser
How Celldex Therapeutics Inc. stock performs during market volatility2025 Historical Comparison & Stepwise Trade Signal Implementation - Newser
Is Celldex Therapeutics Inc. trending in predictive chart modelsShare Buyback & Community Consensus Trade Alerts - Newser
Backtesting results for Celldex Therapeutics Inc. trading strategiesMarket Activity Report & Advanced Swing Trade Entry Plans - Newser
Does Celldex Therapeutics Inc. have high return on assetsTrade Entry Report & AI Powered Market Entry Ideas - khodrobank.com
Analyzing recovery setups for Celldex Therapeutics Inc. investorsWeekly Trading Summary & Weekly High Potential Stock Alerts - Newser
Is Celldex Therapeutics Inc. stock poised for growthWeekly Stock Summary & Short-Term Trading Opportunity Alerts - Newser
How to read the order book for Celldex Therapeutics Inc.CEO Change & Daily Profit Maximizing Tips - Newser
Live market analysis of Celldex Therapeutics Inc.Earnings Growth Report & Smart Investment Allocation Tips - Newser
Custom strategy builders for tracking Celldex Therapeutics Inc.July 2025 Opening Moves & Reliable Price Action Trade Plans - Newser
Is Celldex Therapeutics Inc. gaining market shareJuly 2025 Fed Impact & AI Enhanced Trading Signals - khodrobank.com
will a bounce in celldex therapeutics inc. offer an exitJuly 2025 Pullbacks & Weekly Chart Analysis and Guides - Newser
Is a relief rally coming for Celldex Therapeutics Inc. holdersInsider Buying & AI Enhanced Trade Execution Alerts - Newser
Using economic indicators to assess Celldex Therapeutics Inc. potentialMarket Performance Summary & AI Forecasted Entry and Exit Points - Newser
Should I set a stop loss on Celldex Therapeutics Inc.Volume Spike & Verified Entry Point Signals - khodrobank.com
Is Celldex Therapeutics Inc. impacted by rising ratesMarket Sentiment Report & Comprehensive Market Scan Reports - khodrobank.com
Historical volatility pattern of Celldex Therapeutics Inc. visualizedAnalyst Upgrade & Community Supported Trade Ideas - Newser
What machine learning models say about Celldex Therapeutics Inc.Analyst Upgrade & Proven Capital Preservation Tips - Newser
Is Celldex Therapeutics Inc. stock entering bullish territoryJuly 2025 Outlook & AI Powered Trade Plan Recommendations - Newser
Chart based exit strategy for Celldex Therapeutics Inc.2025 Technical Overview & Real-Time Buy Signal Alerts - Newser
What technical models suggest about Celldex Therapeutics Inc.’s comeback - Newser
Will a bounce in Celldex Therapeutics Inc. offer an exit2025 Market Overview & Consistent Income Trade Ideas - Newser
Is Celldex Therapeutics Inc. on track to beat earningsQuarterly Performance Summary & Entry and Exit Point Strategies - khodrobank.com
Published on: 2025-09-03 03:10:59 - khodrobank.com
Celldex Therapeutics Inc. Recovery Gathers Momentum on Chart SignalsQuarterly Market Review & Verified Momentum Stock Alerts - beatles.ru
Can you recover from losses in Celldex Therapeutics Inc.Insider Buying & Expert-Curated Trade Recommendations - Newser
Analyzing drawdowns of Celldex Therapeutics Inc. with statistical tools2025 Growth vs Value & Free Community Supported Trade Ideas - Newser
How to build a custom watchlist for Celldex Therapeutics Inc.2025 Pullback Review & Daily Stock Trend Reports - Newser
Celldex Therapeutics Inc. Could See a Relief Rally From Support getLinesFromResByArray error: size == 0 - 강소기업뉴스
Celldex Therapeutics’ SWOT analysis: barzolvolimab stock potential amid setbacks - Investing.com
Can Celldex Therapeutics Inc. maintain sales growthJuly 2025 Pullbacks & Free Expert Approved Momentum Trade Ideas - خودرو بانک
How to build a dashboard for Celldex Therapeutics Inc. stockTrade Performance Summary & Community Verified Watchlist Alerts - Newser
Published on: 2025-08-31 20:05:07 - Newser
Relief Rally in Celldex Therapeutics Inc. Stock — Can It Hold getLinesFromResByArray error: size == 0 - 더경남뉴스
Is Celldex Therapeutics Inc. stock bottoming outOil Prices & Capital Protection Trade Alerts - Newser
Finanzdaten der Celldex Therapeutics Inc-Aktie (CLDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Celldex Therapeutics Inc-Aktie (CLDX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Marucci Anthony S | PRESIDENT & CEO |
Nov 11 '24 |
Buy |
26.82 |
11,500 |
308,430 |
40,284 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):